1.
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
by ROWLAND, Malcolm
Annual review of pharmacology and toxicology, 2011, Vol.51 (1), p.45-73
2.
Molecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
by REITER, Eric
Annual review of pharmacology and toxicology, 2012, Vol.52 (1), p.179-197
3.
Allosteric modulation of G protein-coupled receptors
by MAY, Lauren T
Annual review of pharmacology and toxicology, 2007, Vol.47 (1), p.1-51
4.
Novel Computational Approaches to Polypharmacology as a Means to Define Responses to Individual Drugs
by LEI XIE
Annual review of pharmacology and toxicology, 2012, Vol.52 (1), p.361-379
5.
Pharmaco-metabonomic phenotyping and personalized drug treatment
by Nicholson, Jeremy K
Nature, 2006, Vol.440 (7087), p.1073-1077
6.
Circadian rhythms : Mechanisms and therapeutic implications
by LEVI, Francis
Annual review of pharmacology and toxicology, 2007, Vol.47 (1), p.593-628
7.
Pharmacogenomics in clinical practice and drug development
by HARPER, Andrew R
Nature biotechnology, 2012, Vol.30 (11), p.1117-1124
8.
Moving towards individualized medicine with pharmacogenomics
by Evans, William E
Nature, 2004, Vol.429 (6990), p.464-468
9.
Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs
by SHITARA, Yoshihisa
Annual review of pharmacology and toxicology, 2005, Vol.45 (1), p.689-723
10.
Regulation of drug-metabolizing enzymes and transporters in inflammation
by AITKEN, Alison E
Annual review of pharmacology and toxicology, 2006, Vol.46 (1), p.123-149
11.
The Pharmacokinetics of Paliperidone Versus Risperidone
by de Leon, Jose, M.D
Psychosomatics (Washington, D.C.), 2011, Vol.51 (1), p.80-88
12.
Sex differences in pharmacokinetics and pharmacodynamics
by GANDHI, Monica
Annual review of pharmacology and toxicology, 2004, Vol.44 (1), p.499-523
13.
Bioactivation of Drugs: Risk and Drug Design
by WALSH, John S
Annual review of pharmacology and toxicology, 2011, Vol.51 (1), p.145-167
14.
Cyclic Nucleotide Compartmentalization: Contributions of Phosphodiesterases and ATP-Binding Cassette Transporters
by CHEEPALA, Satish
Annual review of pharmacology and toxicology, 2013, Vol.53 (1), p.231-253
15.
Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity
by Smit, M.J
Annual review of pharmacology and toxicology, 2007, Vol.47 (1), p.53-87
16.
Human flavin-containing monooxygenases
by CASHMAN, John R
Annual review of pharmacology and toxicology, 2006, Vol.46 (1), p.65-100
17.
Rate-limited steps of human oral absorption and QSAR studies
by ZHAO, Yuan H
Pharmaceutical research, 2002, Vol.19 (10), p.1446-1457
18.
Genetic polymorphisms of the human MDR1 drug transporter
by SCHWAB, Matthias
Annual review of pharmacology and toxicology, 2003, Vol.43 (1), p.285-307
19.
Shifting emphasis from pharmacogenomics to theragnostics
by Ozdemir, Vural
Nature biotechnology, 2006, Vol.24 (8), p.942-946
20.
Cytochrome P450 and xenobiotic receptor humanized mice
by GONZALEZ, Frank J
Annual review of pharmacology and toxicology, 2006, Vol.46 (1), p.41-64
